ECMOHO Limited Announces Partnership with Vision Care Brand Bausch + Lomb for Sales & Marketing on Pinduoduo – Yahoo Finance

SHANGHAI, China, Oct. 21, 2021 (GLOBE NEWSWIRE) — ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, announced today that it has reached strategic cooperation agreement with the renowned U.S. vision care brand Bausch + Lomb to promote and sell its products and services on the Chinese e-commerce website Pinduoduo. Through the partnership, ECMOHO provide consumer and Chinese family with high-quality eye care products and family health solution to satisfy the rising demand for eye health.

Bausch + Lomb has been a leading vision care company for more than 160 years, and is a global innovation leader who sets the quality standards in this field. As the brand that introduced contact lenses to China, and as the first manufacturer to sell contact lens in China to have passed the ISO (International Organization for Standardization) medical device quality system certification, Bausch + Lomb has become synonymous with contact lenses. Bausch + Lomb has a rich product line, from transparent contact lenses, colored contact lenses, to contact lens care solutions, that fully meet the needs of consumers for achieving clearer vision and improvement in their quality of life.
Pinduoduo, as one of China’s largest e-commerce platforms, has relied upon the concept of communication and sharing as the basis for its unique, new social e-commerce business. Through this cooperation between ECMOHO and Bausch + Lomb on the Pinduoduo platform, ECMOHO and Bausch + Lomb will be able to empower each other with the unique strength respectively. In the future, while bringing more diversified, affordable, and better eye health products to Chinese consumers, the cooperation will also allow brands and platforms to gain deeper operational and sales knowledge to better understand consumer health demands and needs.
Ms. Zoe Wang, Chairman and CEO of ECMOHO, commented: “As a leading online retail service provider in the field of healthcare and medical equipment in China, ECMOHO has been deeply involved in healthcare, medical equipment and other health-related industries since its establishment. International and domestic brands such as Puritan’s Pride, Centrum, Caltrate, Harbin Pharmaceuticals, Johnson & Johnson, Sperry, Haier Biomedical, Abbott, Omron, and now Bausch + Lomb, have established in-depth strategic partnerships with ECMOHO, where our Company provides invaluable professional health content services, health key opinion leaders (KOL) and key opinion consumers (KOC) professional matrices, as well as, through continuous exploration, in-depth operation of new media and new traffic, which together helps to empower our partner brands’ business growth in China.”
About ECMOHO Ltd.
ECMOHO is a leading integrated solutions provider in the health and wellness market in China. The company curates and sells the best global brands and quality products to Chinese health-conscious consumers. Our technology, network and expertise in marketing and distribution empower us to connect families with advanced health supplements, nutrition and food items, personal care products, household healthcare equipment and other wellness products. Through over ten years of operation, ECMOHO has established an ecosystem of trusted products and relationships to provide customized solutions which promote health regeneration, impart therapeutic benefits, and increase longevity to our devoted consumers to sustain health. For more information, please visit
For investor and media inquiries, please contact:
Investor Relations
Email: [email protected]
Safe Harbor Statements
This news release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "going forward," "outlook" and similar statements. Such statements are based upon management's current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, such as the performance of Bausch + Lomb, the Company’s expectations regarding demand for and market acceptance of Bausch + Lomb’s product and the effectiveness of the Company’s targeted marketing of Bausch + Lomb, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

Shares of online retail stocks were taking a beating in Friday trading, with Shopify (NYSE: SHOP) stock falling by 5.2% through 2:37 p.m. EDT, MercadoLibre (NASDAQ: MELI) down by 4.5%, and e-commerce leader (NASDAQ: AMZN) off by 2.3%. As it reported Friday morning, analyst Stephen Ju at Swiss mega-bank Credit Suisse cut his price target on Amazon shares by more than 10% to $4,200, based on his estimate that Amazon will earn only $70.98 per share this year and $79.83 per share next year. Credit Suisse's new earnings projections reflect a reduction of 12% this year, and a staggering 33% reduction in expectations for 2022.
International Business Machines (NYSE:IBM) delivered another set of lackluster results on Wednesday when third quarter results were announced. While returns remain uninspiring, the current valuation may offer an opportunity.
Traders shrugged off Chipzilla's fantastic bottom-line profits and inspiring long-term growth plan to focus on the massive costs of bringing that vision to life.
This tiny, money-losing Trump-linked software company has a stock that is surging, but what's behind all this PHUN?
Matt Bryson, Wedbush SVP, Equity Research, discusses Intel Q3 earnings beat and weak future outlook amid the ongoing chip shortage.
Yahoo Finance's Emily McCormick breaks down the numbers to know from Snapchat's Q3 earnings report. 
What happened Shares of IBM (NYSE: IBM) fell 9.5% on Thursday after the global technology company's third-quarter results came up short of investors' expectations. So what IBM's revenue inched up 0.
Tesla stock hit a new all-time high in Friday trading, and closed at a record. Shares also got a boost Friday from a credit upgrade at S&P. Tesla debt is now BB+ rated, one notch below investment grade. Tesla stock’s new 52-week intraday high is $910 on the nose.
In this article, we discuss the 10 stocks to consider in the portfolio of Nancy Pelosi. If you want to skip our detailed analysis of these stocks, go directly to Nancy Pelosi Stock Portfolio: 5 Stocks To Consider. Former United States President Barack Obama had signed into law the Stop Trading on Congressional Knowledge (STOCK) […]
David Tepper, billionaire investor and one of the world’s top hedge-fund managers, isn't a fan of the stock market, right now.
The company's experimental anti-PD1 drug hit a wall.
There's a good reason why investors should keep an eye on cloud computing stocks. The cloud computing market is forecast to reach $397 billion next year, up 47% from 2020. Here's why they lead the cloud computing pack.
The maker of plant-based meat substitutes released preliminary results for the third quarter, warning that its growth would fall far short of its forecast. Beyond Meat said in a press release that the company was reducing its third-quarter net revenue outlook after reviewing its preliminary results. This marks a sharp deceleration from the company's recent growth rate.
Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying to a record high on Friday.
Welcome to the public markets, hot dog chain Portillo's.
If you owned a $1,000 stake in Berkshire Hathaway when Warren Buffett became the company's CEO more than a half-century ago and held on to your position, you would now own stock worth roughly $22.6 million. While matching that kind of incredible performance over the next 50-plus years is likely out of reach due to the investment conglomerate's already massive size, the company's performance under Buffett's tenure should make it clear why the famous investor is sometimes referred to as the Oracle of Omaha. Berkshire Hathaway's investment portfolio continues to reflect Buffett's focus on high-quality companies that are built to perform over the long term, and it's little wonder that investors around the world continue to look to him for guidance on market-beating stock plays.
If you are looking to own the assets that make the world work, then these three infrastructure stocks will be up your alley.
The company hopes to bring a different approach to electric vehicle manufacturing, but will it succeed?
Shares of 23andMe Holding (NASDAQ: ME) stock slipped in Friday morning trading after the genetic data miner announced that it will spend $400 million to acquire on-demand online medical care and pharmacy services platform Lemonaid Health (not to be confused with Lemonade (NYSE: LMND), the insurance provider). As of 11 a.m. EDT, 23andMe shares are down 4.2%. 23andMe noted that bringing Lemonaid Health's "innovative telemedicine and prescription drug delivery services" onboard could be "an important step in transforming the traditional primary care experience and making personalized healthcare a reality."
The second half of October has been one of the most active periods for the stock market in quite some time. Not only did the major indexes, including the SPDR S&P 500 ETF (NYSE: SPY) and SPDR Dow Jones Industrial Average ETF Trust (NYSE: DIA) hit fresh, all-time highs, retail traders, are finally getting their fill of volatile small-caps and short squeeze stocks. It’s been a long time since newsfeeds were flooded with meme stock headlines that included discussions about AMC Entertainment Holding